Policy & Medicine January 27, 2025
Thomas Sullivan

Sometime in the future, as you are watching your favorite television show or sporting event, amongst the DTC ads featuring butterflies and very happy people you may also be seeing drug prices float across your screen.

Recently, The Drug-price Transparency for Consumers Act of 2025, was re-introduced at the beginning of Congress by Senators Dick Durbin and Chuck Grassley. The legislation aims to set a new standard in the transparency of prescription drug advertising by mandating the inclusion of the list price of prescription drugs in all direct-to-consumer (DTC) advertisements, a move intended to provide consumers with pricing information upfront.

Specifically, the bill stipulates that all DTC advertisements for prescription drugs and biological products must disclose the list price, defined...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Patient / Consumer, Pharma, Pharma / Biotech
From discovery to delivery: Finding an investment edge in biopharma services
GLP-1 drug approvals: A breakdown
Trump administration affirms drug price talks, but will seek input to ‘improve’ program
How genAI and precision medicine will change healthcare in 2025
Healthcare’s outlook in 2025: New administration spells uncertainty, but hope remains

Share This Article